Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Minimal recovery in HPV vaccination reported in Japan despite recommendations
July 17th 2024HPV vaccination coverage in Japan remains critically low despite the resumption of proactive recommendations by the Ministry of Health, Labour, and Welfare, highlighting the need for stronger cervical cancer control measures.
Women report higher psoriatic arthritis burden than men
July 16th 2024A global survey highlights that female patients with psoriatic arthritis experience more tender joints, skin issues, and musculoskeletal tenderness than male patients, emphasizing the need for gender-sensitive treatment approaches.
AI vs. human: A comparative study on summarizing incontinence research
July 3rd 2024Mubashir S. Billah, MD, discusses a study presented at the 2024 AUA Annual Meeting, which evaluates the efficacy of AI-generated summaries against traditional human-written summaries in the field of incontinence research.
FDA grants fast track to 99mTc-maraciclatide for endometriosis diagnosis
Published: July 2nd 2024 | Updated: July 2nd 2024Serac Healthcare’s 99mTc-maraciclatide, a new radio-labelled tracer, gains FDA Fast Track Designation for its potential to improve non-invasive diagnosis of superficial peritoneal endometriosis in patients aged 16 and older.